Further thoughts to expand on what I expect or would like to see in tomorrows quarterly:
- Circa $600,000-$1Million in product revenue (another 200%+ increase QoQ possible?)
- Circa $4Million+ in services revenue. This would be $1.5Million Hologic, $900K BARDA receipts, $250K Burnet Revenue, plus other existing deals ( circa $1.6Million) So a total of roughly $4.3Million?
- Burnet update with revenues reflected in the services side
- Update on Hologic payments and status of this deal
- Update on the PHK study which has been going for some time in the US
- Update on Febridx study (number of patients tested, and or number of bacterial patients tested)
- Clarity on other services deals progressing and whether there is any updates
Time will tell. Wish they didnt wait until a Friday to release this but.
Add to My Watchlist
What is My Watchlist?
